Group at a Glance

  • 28 members
  • 23 members have doctorate or medical degrees
  • Members' backgrounds include: Biochemistry, Bioengineering, Biology, Epidemiology, Genetics, Medical Biophysics, Neuroscience, Oncology, Physical Chemistry, Psychobiology, and Toxicology

What Matters to Our Clients

Client Base

We measure our value on a simple metric: our clients stay with us for many years. Often remaining with us after being acquired, they like the fact that we have a remarkable degree of stability among our people. Our clients can rely on the consistency of a solid team to keep pace with their growth.

Working with world leaders in industry and academia, we also represent start-ups and non-profits in the biotech and life sciences space. Our experienced understanding of the issues at stake means that we bring realistic solutions to the table.

Team Approach

Efficient and cost-effective client service is a core firm value. In our Biotechnology Group, that value means working with our Chemical & Materials Technologies Group and our Pharmaceutical Group when their specialized expertise will benefit a client’s project. Our teams routinely include support from our paralegal group and our International Filing Department to contain costs and deliver value.

Technical Depth and Breadth

When it comes to advanced scientific degrees, we field the largest biotechnology group in New England. Aggressively recruiting people who are closest to advancing technology, we quickly grasp the nuances of complex biotechnology matters.

Our clients appreciate the easy way we communicate with their inventors and scientists on the fine distinctions of a particular innovation, and with their business executives on issues that impact the future commercial value of their technology.

The services we provide include: IP strategic planning; patent and trademark acquisition and enforcement; studies on patentability, infringement, and validity; IP audits and due diligence; licensing and technology transfer; interferences; and competitor analysis.

Areas of Expertise

Examples of our group's areas of expertise include:

Contract All | Expand All

  • Detection systems
  • Data mining and analysis
  • Diagnostic assays
  • Molecular modeling
  • Pattern recognition
Cell biology
  • Cloning & transgenic technologies
  • Gene discovery
  • Gene therapy
  • Pharmacogenomics
  • Population genetics
  • Proteomics
  • Quantitative genetics
Medical devices
Medical disciplines
  • Allergy
  • Arthritis
  • Bone & mineral diseases
  • Cancer
  • Cardiovascular
  • Dermatology
  • Developmental biology
  • Diabetes
  • Endocrinology, metabolism & lipids
  • Gastroenterology
  • Hematology
  • Immunology
  • Infectious disease
  • Neurology
  • Obstetrics & gynecology
  • Ophthalmology
  • Orthopedics
  • Psychiatry
  • Pulmonary
  • Renal
  • Rheumatology
  • Tissue engineering
  • Toxicology
  • Transplantation
  • Vaccines
  • Bacteriology
  • Mycology
  • Parasitology
  • Probiotics
  • Virology
Molecular biology
Molecular biophysics
Neuroscience / Neurobiology
  • Computational neuroscience
  • Neuroanatomy
  • Neurodegenerative diseases
  • Neurophysiology
  • Phychobiology
  • Psychopharmacology
Plant biology
Sequencing technologies
  • Nucleic acids
  • Polysaccharides
  • Proteins
Stem cell biology
Systems biology
  • Computational biology
  • Synthetic biology
View All Group Members

Representative Group Clients
  • Ablynx
  • Biogen Idec
  • Boston Children's Hospital
  • Brown University
  • Dana Farber Cancer Institute
  • Dyax Corporation
  • Epizyme, Inc.
  • Jackson Laboratory
  • Lantheus Medical Imaging
  • Ludwig Institute for Cancer Research
  • Massachusetts General Hospital
  • Massachusetts Institute of Technology
  • OrbiMed
  • Oxford Bioscience Partners
  • PathoGenetix
  • Progenics Pharmaceuticals Inc.
  • rEVO Biologics
  • Selecta Biosciences, Inc.
  • Shire Pharmaceuticals
  • Synta Pharmaceuticals, Inc.
  • University of Florida Research Foundation, Inc.
  • University of Massachusetts
  • University of South Florida
  • University of Vermont
  • Yale University
May 18, 2015 - Managing IP Magazine Recognizes Wolf Greenfield

April 8, 2015 - Diagnostic patenting since Myriad: an update

January 28, 2015 - Looking Behind The Different Invalidation Rates Of Oppositions And IPRs

December 16, 2014 - Chelsea Loughran talks about CRISPR in Xconomy

Novartis AG v Lee (decided 1/15/14) - New Method for Calculating U.S. Patent Term Adjustment

October 20, 2014 - 22 Wolf Greenfield Attorneys Named to 2014 Massachusetts Super Lawyers List

October 20, 2014 - 20 Wolf Greenfield Lawyers Named to 2014 Massachusetts Rising Stars List

September 26, 2014 - Pat Granahan comments on the battle to own CRISPR

August 18, 2014 - Ten Wolf Greenfield Attorneys Named to The Best Lawyers in America© 2015

July 8, 2014 - Pat Granahan and Chelsea Loughran quoted on CRISPR-Cas in Nature Biotechnology

June 23, 2014 - Patrick Waller interviewed by Radio Entrepreneurs

June 18, 2014 - GenomeWeb quotes Chelsea Loughran on IP landscape surrounding CRISPR-Cas9

May 22, 2014 - Wolf Greenfield Recognized by Managing IP Magazine

April 17, 2014 - Chelsea Loughran quoted in The Scientist on first awarded CRISPR-Cas9 patent

April 16, 2014 - Chelsea Loughran quoted in MIT Tech Review on first awarded patent for engineered CRISPR-Cas9 system

March 2014 - CRISPR/Cas-9: An Exciting Addition to Genomic Editing

March 5, 2014 - Doug Wolf featured as the expert for the month of March

February 2014 - The New World of Diagnostic Testing Post-Myriad

February 5, 2014 - WOLF GREENFIELD WEBCAST REPLAY: CRISPR/Cas-9 and the IP Landscape for a Revolutionary New Technology

January 30, 2014 - "Intellectual Property for Startups: Making It Work on a Limited Budget" Webinar - Replay Now Available

December 2013 - Recovering Patent Life with Patent Term Extension

January 2, 2014 - Dyax Corp. Prevails at PTAB by Proving 11 Months of Diligence

October 21, 2013 - Fifteen Wolf Greenfield Lawyers Named to 2013 Massachusetts Rising Stars List

October 21, 2013 - Twenty Wolf Greenfield Attorneys Selected to 2013 Massachusetts Super Lawyers List

October 18, 2013 - IP ALERT - European Patent Office Reverses Two-Year Deadline on Divisional Applications

October 17, 2013 - WOLF GREENFIELD SEMINAR: Strategically Building a Valuable Worldwide Patent Portfolio - Replay Now Available

October 2, 2013 - Chelsea Loughran and Patrick Waller interviewed Radio Entrepreneurs on Myriad case

September 12, 2013 - Chelsea Loughran and Patrick Waller present at Cowen and Company Medtools Unlocked Conference in NYC

September 9, 2013 - Pat Granahan and Ed Walsh present at AUTM's 2013 Eastern Regional Meeting

August 15, 2013 - Ten Wolf Greenfield Attorneys Named to The Best Lawyers in America 2014 List

August 2013 - Rainmaker Q&A: Wolf Greenfield's Edward Gates

July 12, 2013 - Who Owns Your DNA? What Innovators Need to Know About the Supreme Court's Decision

June 14, 2013 - IP ALERT - Supreme Court Says Isolated Natural DNA Not Patent Eligible But Leaves Open Questions Regarding Synthetic DNAs

June 14, 2013 - Patrick Waller quoted in Law360 on gene patenting.

June 2013 - Wolf Greenfield Attorneys Named to IAM 1000 World’s Leading Patent Practitioners List

May 13, 2013 - CLIENT ALERT— Supreme Court’s Bowman Decision Addresses Self-Replicating Technologies

May 1, 2013 - Dan Young quoted in Massachusetts Lawyers Weekly on Myriad

Wrigley Jr. Co. v. Cadbury Adams (6/22/12) - Influence of Secondary Considerations in Overcoming Prima Facie Case of Obviousness

April 24, 2013 - WOLF GREENFIELD WEBINAR: Key Patent Litigation Decisions and the ITC as Alternate Forum - Replay Now Available

April 2013 - Wolf Greenfield Tops the Boston Business Journal’s List of Largest Area Intellectual Property Law Firms

April 10, 2013 - Wolf Greenfield Patent Attorneys Co-Author Amicus Brief on Behalf of Boston Patent Law Association

April 10, 2013 - Rob Walat quoted in Mass High Tech

March 22, 2013 - Ed Walsh quoted on "first-inventor-to-file" changes

March 22, 2013 - Patrick Waller quoted on the "First-Inventor-to File" system

March 11, 2013 - Patrick Waller quoted in Law360 on first-to-file patent system

March 2013 - Top Actions to Consider in Light of the Biosimilar Act

February 21, 2013 - Wolf Greenfield Attorney Recognized for Pro Bono Service by Women’s Bar Foundation

February 12, 2013 - Deadline approaches for patent protections

February 5, 2013 - Wolf Greenfield Named Elite Trademark Law Firm in World Trademark Report 1000

January 29, 2013 - Preparing for the “First Inventor to File” Transition

January 18, 2013 - Ed Walsh was quoted in a Law360 article on Patent Reform

December/January 2013 - Third Party Submissions in Pending Patents

October 22, 2012 - Fifteen Wolf Greenfield Lawyers Highlighted in 2012 Massachusetts Super Lawyers List

October 18, 2012 - WOLF GREENFIELD SEMINAR: What You Need to Know to Prepare for the "First Inventor to File" Transition - Replay Now Available

September 19, 2012 - Eleven Wolf Greenfield Attorneys Selected for 2013 Best Lawyers in America®

September 6, 2012 - Federal Circuit Establishes New Standard on Divided Infringement and Inducement

July 27, 2012 - Chelsea Loughran quoted in Law360 on the new First-To-File rules

July 13, 2012 - Jenny Chen spoke at the BioTaiwan 2012 conference

June 2012 - Wolf Greenfield Named to IAM 1000 World’s Leading Patent Practitioners List

June 2012 - GBLS Recognizes Wolf Greenfield with 2012 Associates Drive Award

In Re Hyon (5/24/12) - Federal Circuit Clarifies Substantial Evidence Standard on Appeal for Questions of Motivation to Combine

In re MSTG, Inc (4/9/12) - No Settlement Negotiations Privilege

Aventis Pharma v. Hospira (4/9/12) - Federal Circuit Finds Inequitable Conduct For Failure To Cite Prior Art Under the Heightened Therasense Standard

AFT Trust. v. J&L Fiber (4/3/12) - Prosecution History Can Be Used During Claim Construction

March 26, 2012 - IP ALERT - Supreme Court Invalidates Process Claims in Prometheus

Marine Polymer v. HemCon (decided 3/15/12) - Intervening Rights Cannot Be Triggered by Argument Alone in Reexaminations

In re Erik P. Staats and Robin P. Lash (3/5/2012) - Federal Circuit Rejects Restrictions on Broadening Claims in Reissue Applications

ClearValue v Pearl River Polymers (2/17/12) - A Range With No Special Features Can Anticipate Sub-range

In re Google, Inc. (decided 2/6/12) - Substance of Emails Determines Attorney-Client Privilege Protection

January 31, 2012 - Navigating Patent Eligibility for Process Claims

December 2011 - Neil Ferraro Named 2012 Boston Patent Law Association President

January 3, 2012 - Wolf Greenfield Welcomes 2012 Promoting Seven Lawyers to New Positions

November 2011 - America Invents Act: The Implications of Patent Reform

October 12, 2011 - Wolf Greenfield Sponsored MIT Forum Event on October 12

In re Stepan (decided 10/5/11) - BPAI Triggers “New Ground of Rejection” When Changing Statutory Basis of Rejection

September 2011 - America Invents Act – Patent Reform is Finally Here

September 9, 2011 - IP ALERT—Senate Endorses The Long-Awaited Patent Reform

Markem-Imaje Corp. v. Zipher Ltd (decided 9/9/11) - Same Claim Terms Can Have Different Meanings Within Different Limitations

September 8, 2011 - Janice Vatland Was a Panelist at BioForward’s 2011 Bioscience Vision Summit

Classen v. Biogen Idec (decided 8/31/11) - Process Claims With Physical Implementation Steps May Be Patent-Eligible

AIA Engineering v Magotteaux (decided 8/31/11) - Federal Circuit Muddies Reissue Application Practice

August 30, 2011 - Patricia Granahan Named To Martindale-Hubbell® Bar Register of Preeminent Women Lawyers™

August 16, 2011 - National Institutes of Health Intervenes to End Patent Infringement Suit Against The Jackson Laboratory Concerning Mouse Models for Alzheimer’s Research

July 2011 - IP ALERT—Federal Circuit Clears Nucleic Acid Claims But Muddies Waters on Diagnostic Method Claims in Myriad Decision

August 9, 2011 - Patricia Granahan Named to Arrive Magazine’s List of Top Women Lawyers

March 2011 - The Patentability of Stem Cells: A Look at the UK and US Situations

February 25, 2011 - Managing the Pace of Patent Applications

February 17, 2011 - WOLF GREENFIELD SEMINAR: Managing IP Risks: The Importance of Obtaining Freedom to Operate Guidance - presentation now available

January 7, 2011 - Janice Vatland to present at MassBio on the Biologics Price Competition and Innovation (BPCI) Act

January 1, 2011 - Wolf Greenfield filed 2,749 patent applications and 688 trademark applications in 2010.

December 2010 - Wolf Greenfield was ranked #1 in number of patents filed and number of patent attorneys in Mass High Tech’s annual survey

December 17, 2010 - Implementing the BPCI Act: Many Challenges for the FDA

November - Wolf Greenfield sponsored the 11th Annual HBS Health Industry Alumni Conference

November 2010 - Be prepared for biosimilars

October 2010 - iPS Cell Patent Snapshot

August 22, 2010 - Hunter Baker, Ed Gates and Chelsea Loughran presented at the American Chemical Society’s Fall National Meeting

August 20, 2010 - BBJ survey ranks Wolf Greenfield #1 in patent attorneys, patents filed and patents obtained

July 2010 - Risks of False Marking: Reducing Your Exposure

June 2010 - Bilski ruling from US Supreme Court

July 2, 2010 - Industry Groups, Practitioners React To High Court Decision on Method Patents

July 7, 2010 - A Wolf Greenfield Webinar: Forecasting the Future of Method Patents Post-Bilski — archived replay of webinar now available

June 28, 2010 - CLIENT ALERT— Supreme Court Leaves Door Open to Business Method Patents

June 17, 2010 - WOLF GREENFIELD SEMINAR: Strategically Building and Monetizing a Patent Portfolio - replay now available

June 2, 2010 - Wolf Greenfield’s litigation team secured summary judgment of no patent infringement for our client The Jackson Laboratory

April 16, 2010 - Patent Applications Must Have Separate Written Description

April 14, 2010 - CLIENT ALERT— Federal Circuit Decision Reaffirms Separate Written Description Requirement

April 2, 2010 - Practitioners See Little Change From Ariad Decision, Caution Inventors on When to File

April 2, 2010 - CLIENT ALERT— The New Biosimilar Pathway: Biologics Price Competition and Innovation Act

March 31, 2010 - Gene Patent Ruling Could Shake Up Biotech

March 31, 2010 - Look, You Wanna Invent? You'd Better WRITE IT DOWN

February 26, 2010 - Wolf Greenfield wins key claim construction ruling for The Jackson Laboratory

February 19, 2010 - More Organizations Ask PTO to Recalculate Term Adjustments

January 2010 - Michael Siekman interviewed by IP Lawcast

January 13, 2010 - CLIENT ALERT— Federal Circuit Affirms Decision Finding USPTO Miscalculates Patent Term Adjustment

November 18, 2009 - WOLF GREENFIELD SEMINAR: Biotechnology Patent Drafting: New Strategies for New Times- replay now available

October 15, 2009 - CLIENT ALERT — USPTO Rescinds Controversial Rules Restricting Patent Applications

October 2009 - Court Case on Patent Delays Holds Appeal for Industry

October 10, 2009 - Federal Circuit Confirms Diagnostic and Therapeutic Methods Can be Patentable Subject Matter

September 25, 2009 - Lack of timing awareness can mean missed revenue

September 24, 2009 - CLIENT ALERT — Federal Circuit Confirms Diagnostic and Therapeutic Methods Can be Patentable Subject Matter

May 14, 2009 - Our clients Cambridge NanoTech and E Ink named winners of SBANE’s New England Innovation Awards, and our client Formulatrix named as finalist

April 10, 2009 - Gilead's Hypertension Drug Darusentan Will Likely Receive Patent

March 25, 2009 - CLIENT ALERT — Federal Circuit Decision on Controversial PTO Rules

February 2009 - Maximizing Intellectual Property Value in Tough Economic Times- Seminar replay now available

November 12, 2008 - Navigating Technology Collaborations and Joint Ventures—Wolf Greenfield seminar

August 2008 - Wolf Greenfield wins three more years of patent protection for Shire Pharmaceuticals' ELAPRASE treatment

June 6, 2008 - Biotech, IT Stalemate Puts Breaks on IP Reform Law

June, 2008 - Stem Cell Gold Rush

April 11, 2008 - "Patent Issues & Potential Problems" – Invention to Venture Conference / University of Vermont

February 7, 2008 - An Entrepreneur's Guide to the Intellectual Property Galaxy

January 9, 2008 - Wolf Greenfield, Boston, Names Two New Shareholders - Boston Intellectual Property Law Firm Promotes Teja, Trevisan

August 8, 2007 - Wolf Greenfield Names Van Amsterdam to Head Biotech Law Practice

March 29, 2007 - Wolf Greenfield Client Diomed Holdings Wins $12.5 Million Award in Patent Case - Jury Finds Two Defendants Infringed Patent for Varicose Vein Treatment

March 21, 2007 - Wolf Greenfield Names Oyer President and Managing Partner - Lawyer/Scientist Takes Reins at Boston Intellectual Property Law Firm

March 2007 - Can a Biological Sequence be Copyrighted?

January 9, 2007 - Supreme Court Rules in MedImmune Biotech Patent Case; Expert Lawyer Can Comment

January 2, 2007 - Supreme Court Throws Patent Owners a Curveball

November 2006 - Accelerated Examination of Patent Applications: Too Good To Be True?

June 23, 2006 - CLIENT ALERT — Supreme Court Dismisses Case Involving Patentability of Natural Phenomena

June 22, 2006 - Supreme Court Dismisses Case Involving Patentability of Natural Phenomena

Q&A Booklet - Q&A on Patents

Q&A Booklet - Q&A on Intellectual Property Litigation

Q&A Booklet - Q&A on Licensing and Transactions